Propranolol prevents life-threatening arrhythmias in LQT3 transgenic mice: Implications for the clinical management of LQT3 patients()

BACKGROUND: The efficacy of beta-blockers for treatment of patients with long QT syndrome type 3 (LQT3) has been repeatedly questioned, and it has been suggested that they might be detrimental for this genetic subgroup of patients with long QT syndrome (LQTS). The disquieting consequence has been th...

Descripción completa

Detalles Bibliográficos
Autores principales: Calvillo, Laura, Spazzolini, Carla, Vullo, Eleonora, Insolia, Roberto, Crotti, Lia, Schwartz, Peter J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3882517/
https://www.ncbi.nlm.nih.gov/pubmed/24135497
http://dx.doi.org/10.1016/j.hrthm.2013.10.029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3882517/
https://www.ncbi.nlm.nih.gov/pubmed/24135497
http://dx.doi.org/10.1016/j.hrthm.2013.10.029

Ejemplares similares